MD vs PSA · P/E 11, $1.93B cap vs rev $4.82B
Mednax Inc (MD) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
PSA (PSA) common stock.
MD does not have a complete income-statement cache yet.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
MD currently screens at market cap $1.93B and trailing P/E 11.4. PSA currently screens at market cap $0.
Not investment advice. Open the MD and PSA stock pages for the full models.
Not investment advice.